🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies the side effects of bevacizumab and anetumab ra...
Status
Active Not Recruiting
Location
UC Irvine Health/Chao Family Comprehensive Cancer Center
Start Date
2018-10-12
Trial ID
NCT03587311
Treatments Being Tested
Background: Anetumab ravtansine is a new drug. It kills cancer cells that ...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2016-07-19
Trial ID
NCT02839681
Treatments Being Tested
This phase I trial studies the side effects and best dose of anetumab ravta...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-12-09
Trial ID
NCT03816358
This phase I/II trial studies the side effects and how well pembrolizumab w...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2018-10-04
Trial ID
NCT03126630
Treatments Being Tested
To characterize the safety, tolerability, pharmacokinetics and immunogenici...
Status
Completed
Location
Multiple Locations
Start Date
2016-04-14
Trial ID
NCT02696642
Treatments Being Tested
The primary objectives of the Phase I study 15404 are to evaluate the safet...
Status
Completed
Location
National Cancer Center Hospital East
Start Date
2015-08-14
Trial ID
NCT02485119
Treatments Being Tested
The primary objective of this study is to: -Test the activity/response rat...
Status
Completed
Location
Yale Cancer Center
Start Date
2017-05-11
Trial ID
NCT03023722
Treatments Being Tested
The key purpose of the main part of the study is to assess efficacy and saf...
Status
Completed
Location
Mayo Clinic Hospital
Start Date
2017-05-26
Trial ID
NCT03102320
Treatments Being Tested
Characterize the safety, tolerability, ECG effects, pharmacokinetics and im...
Status
Completed
Location
UCLA-Santa Monica Medical Center
Start Date
2016-09-07
Trial ID
NCT02824042
Treatments Being Tested
The purpose of this study is to enable patients with solid tumors, who rece...
Status
Terminated
Location
University of Chicago
Start Date
2019-06-03
Trial ID
NCT03926143
Treatments Being Tested